AREV Life Sciences Global Corp.
AREVF · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $2 | $7 | $39 | $0 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $56 | $54 | $51 | $49 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $69 | $74 | $103 | $67 |
| Property Plant & Equip (Net) | $145 | $158 | $172 | $186 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $145 | $158 | $172 | $186 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $213 | $232 | $275 | $253 |
| Liabilities | – | – | – | – |
| Payables | $792 | $773 | $828 | $805 |
| Short-Term Debt | $145 | $145 | $62 | $29 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $0 | $0 | $0 |
| Total Curr. Liab. | $1,376 | $1,366 | $1,288 | $1,205 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $1,376 | $1,366 | $1,288 | $1,205 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $13,712 | $13,712 | $13,712 | $13,667 |
| Retained Earnings | -$17,867 | -$17,838 | -$17,717 | -$17,548 |
| AOCI | $101 | $101 | $101 | $101 |
| Other Equity | $2,891 | $2,891 | $2,891 | $2,827 |
| Total Equity | -$1,163 | -$1,134 | -$1,013 | -$953 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $213 | $232 | $275 | $253 |
| Net Debt | $144 | $138 | $22 | $29 |